Tri-estarylla Kit
Product Images NDC 50090-7861

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tri-estarylla (NDC 50090-7861). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907861)

Label Image (Lbl500907861)
Not available.*
FDA Label Image

Tri-estarylla-blister (Tri Estarylla Blister)

FDA Label Image

Chemical Structure 1 (Tri Estarylla Chemical Struc)

FDA Label Image

Fig 2 (Tri Estarylla Fig 1)

Fig 2 (Tri Estarylla Fig 1)
This text is about various studies related to women's contraceptive use, including the NICHD Women's Contraceptive Study, French E3N cohort Study, Shangal Women's Health study, The Nurses' Health Study I, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The text includes information about ever use and current use of contraceptives, along with effect estimates.*
FDA Label Image

Chart (Tri Estarylla Fig 2)

Chart (Tri Estarylla Fig 2)
This information appears to be related to different methods of contraception ranging from implants, injections, intrauterine devices, sterilization to birth control pills, condoms, and natural family planning methods like avoiding sex during fertile days. It provides a comparison between the effectiveness of various contraceptive methods in preventing pregnancies.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.